Loading...
HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression
Liu, Hanqing Lu, Ziwen Shi, Xiaofeng Liu, Lanlan Zhang, Peishan Tu, Zhigang
Liu, Hanqing
Lu, Ziwen
Shi, Xiaofeng
Liu, Lanlan
Zhang, Peishan
Tu, Zhigang
Citations
Altmetric:
Genre
Journal article
Date
2021-08-10
Advisor
Committee member
Department
Cancer and Cellular Biology
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.1016/j.jbc.2021.100996
Abstract
Mantle cell lymphoma (MCL) is an especially aggressive and highly heterogeneous mature B-cell lymphoma. Heat shock protein 90 (HSP90) is considered an attractive therapeutic target in a variety of cancers, including MCL, but no HSP90 inhibitors have succeeded in the clinical trials to date. Exploring fine mechanisms of HSP90 inhibition in cancer cells may shed light on novel therapeutic strategies. Here, we found that HSP90 knockdown and continuous inhibition with ganetespib inhibited growth of MCL cells in vitro and in vivo. To our surprise, transient exposure over 12 h was almost as efficient as continuous exposure, and treatment with ganetespib for 12 h efficiently inhibited growth and induced G1 cell cycle arrest and apoptosis of MCL cells. Transcriptome analysis complemented by functional studies was performed to define critical MCL signaling pathways that are exceptionally sensitive to HSP90 inhibition and vital to cell fate. Six genes (cell division cycle 6, cell division cycle 45, minichromosome maintenance 4, minichromosome maintenance 7, RecQ-mediated genome instability 2, and DNA primase polypeptide 1) involved in DNA replication and repair were identified as consistently downregulated in three MCL cell lines after transient ganetespib treatment. E2F1, an important transcription factor essential for cell cycle progression, was identified as a ganetespib target mediating transcriptional downregulation of these six genes, and its stability was also demonstrated to be maintained by HSP90. This study identifies E2F1 as a novel client protein of HSP90 that is very sensitive and worthy of targeting and also finds that HSP90 inhibitors may be useful in combination therapies for MCL.
Description
Citation
Liu H, Lu Z, Shi X, Liu L, Zhang P, Golemis EA, Tu Z. HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression. J Biol Chem. 2021 Aug 10;297(2):100996. doi:10.1016/j.jbc.2021.100996.
Citation to related work
Elsevier
Has part
Journal of Biological Chemistry, Vol. 297, Iss. 2
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu